Montreal Scientists Propel the Future with Groundbreaking Advances in ...
In the vibrant city of Montreal , a group of pioneering scientists is pushing the boundaries of renewable energy with groundbreaking advancements in algae biofuel research.
Montreal , July 30, 2025 - Modern medicine is largely reactive—treating illness only after symptoms emerge. But a new study from the Research Institute of the McGill University Health Centre ( The Institute) and McGill University points to a more proactive future : one where silent signs of infection are detected before we even feel sick. In a world first, this study has led to the ...
A Promising Breakthrough in the Fight Against Cancer
Work carried out in the laboratory of Dr. André Veillette, Director of the Molecular Oncology Research Unit at the Montreal Clinical Research Institute (IRCM) and Full Professor in the Department of Medicine at the Université de Montréal , in collaboration with scientists from several countries, and published in the journal Nature Communications, represents a major breakthrough in the fight ...
The Genome Foundry is now one of Canada's first academic facilities where Canadian scientists can design, test and refine potential cell therapies all in one place—from early discovery to studies that predict how treatments will affect real patients.
2025 Highlights
A record $5.3M donated to the IRCM to advance research and training. Supporting Emerging Talent: $309,000 in excellence scholarships awarded to propel the next generation of scientists . An ongoing major fundraising campaign to sustain research and innovation.
The Université de Montréal's Institute for Research on Exoplanets will receive $10 million to ensure the sustainability of its activities. Leaders in exoplanet research, iREx scientists have made discoveries that profoundly changed what we know about worlds beyond our solar system.
An innovative cancer treatment for solid tumours
A CCS-awarded project has discovered an innovative cancer therapy using bacteria and magnetism which is being further developed by a Montreal -based company.
Clinical trials for a new ALS drug took place at the Neuro Hospital in Montreal and the results are being called a 'breakthrough.'
27 million investment for the Montral Biosphre
With this planned joint investment, the Government of Canada, the Government of Québec, and the City of Montréal have reaffirmed their commitment to environmental education, access to science, citizen engagement, and the protection of natural heritage for future generations.
An in-depth analysis of Montreal's biotech ecosystem (updated April 2026). Key companies, startups, research institutions, and the economic drivers of this top life sciences hub — including the latest funding rounds, clinical milestones and the Quebec Life Sciences Strategy 2025-2028.